After being fired, I became the light of medicine

Chapter 141: Put some pressure on the Germans (Subscription required)

After returning to Qingshan Pharmaceutical, Zhang Yang quickly found the contact information of Hans, the vice president of BI Company, on his mobile phone.

This was left over from my previous participation in the "Global Kidney Disease Summit".

After thinking for a moment, he typed:
"President Hans, can you receive my message?"

After the message was sent via WhatsApp (similar to WeChat abroad), Hans responded quickly.

"Zhang, I'm glad to hear from you."

Zhang Yang felt relieved and then tried to test:

"Hans, I noticed that the 'BI-Toxin Filtration Catalyst' that your company promoted at the 'Kidney Summit' has now completed Phase I clinical trials. I am very interested."

"I wonder if there can be some cooperation or trade between us?"

"Cooperation? Deal?"

Hans' reply came quickly, accompanied by a surprised expression, obviously a little surprised.

Zhang Yang continued to probe:
"Yes, I see that the Phase I clinical data released by your company is not very good. If you have the idea of ​​trading patents, I am quite interested. As you know, we also have R&D projects related to kidney dialysis."

"Of course, cooperation is also possible."

This time Hans was sure that Zhang Yang was serious. About a minute later, he replied:
"We are in a bit of trouble right now, but the company has no intention of trading the 'Toxin Filtering Catalyst' patent. However, I can help you submit the cooperation you mentioned to the president. You know, I can't make the final decision on this matter."

"By the way, how do you want to cooperate? Shall we work together to develop the 'Toxin Filtering Catalyst'?"

Zhang Yang was not surprised by this reply. Just as Fang Hanliang had said before, BI Company could not sell off the patent immediately just because the Phase I clinical trial data was not as good as expected. At least it would take some time for it to find out that there was little hope before it would find a way to deal with it.

As for the cooperation plan, he had actually already thought about it a long time ago.

The "toxin filtration catalyst" developed by BI is specifically used in extracorporeal dialysis machines and needs to be used in conjunction with dialysis machines.

What he wanted to obtain was not the drug itself, but the effective drug ingredient in it that could decompose large molecular toxins.

He hopes to obtain a patent for a compound that can decompose large-molecule toxin drugs, and then use it to develop a drug that can directly enter the human body, decomposing and crushing the large-molecule toxin drugs in the human body.

Finally, the "Kidney Toxin Clearing Dialysis Needle" is used to excrete small molecule toxins from the body, thereby increasing the toxin clearance rate.

It can be said that these are two completely different technical routes from BI’s “toxin filtering catalyst”.

"No, we are not collaborating on the development of 'toxin filtering catalysts'. We will not participate in your research and development progress. We only hope to obtain the patent license for this drug."

"To put it simply... we plan to conduct secondary research and development based on the patent of this drug and develop a new drug."

"So, we hope to obtain a permanent buyout of the patent license."

"As for the patent licensing fee, we are willing to pay 5000 million US dollars, equivalent to 3.5 million RMB."

Hans quickly understood what Zhang Yang meant. Patent licensing transactions are actually a very common business model in the pharmaceutical field.

Simply put, the original patent still belongs to BI, but Tsingshan Pharmaceutical can conduct research and development based on this patent.

As for whether or not we can develop drugs, or how to distribute dividends after developing new drugs using patents, these can be discussed in detail slowly.

"Okay, Zhang, I can ask the president about this for you."

"Okay, thank you then."

Zhang Yang ended the call and felt slightly relieved.

To be honest, he was not completely sure about the deal, and it all depended on the decision of BI company.

the other side,
Tall and thin with blond hair, young Hans quickly came to the office of President Markus Duesmann.

President Dussmann is in his fifties and is a typical German. There are almost no other decorations in his office except for the dark wooden desk and the wooden clock hanging on the wall.

Even the shape of the desk is square, with an extreme solemnity and seriousness.

The desk surface is always spotless, and all the documents are neatly arranged, just like the impression given by President Duesmann - rigorous, even a little old-fashioned.

Every time Hans walked into the office, there was an indescribable solemnity. Seeing President Dussmann concentrating on processing documents, he walked up to him and said respectfully:

"Mr. President, I am sorry to bother you. I just received an inquiry about our 'BI-Toxin Filtration Catalyst' business transaction, so I came to report to you."

"Zhang Yang, the boss of Huaxia Qingshan Pharmaceutical, is very interested in our patent for 'toxin filtering catalyst'. He wants to buy out the patent or start cooperation with us."

"Buy out the patent?"

President Dusman slowly put down the documents in his hand and shook his head:

"It's impossible to buy out the patent. Although our 'BI-toxin filtering catalyst' has run into some trouble, we don't lack the money."

"Well, that's what I told Qingshan Pharmaceutical, so they proposed cooperation."

"Simply put, they hope to obtain the patent license for our 'BI-toxin filtration catalyst' and then conduct secondary research and development based on our patent to develop new drugs."

New medication?

Dusman frowned slightly, but after a moment, he shook his head again:
"Hans, I am not interested in their proposal to purchase patent licenses. I think the most important thing we should do now is to focus on the drug research and development of our 'BI-Toxin Filtration Catalyst' rather than commercial cooperation." Hans was slightly stunned.

To be honest, as a young vice president, he is not opposed to business cooperation with other pharmaceutical companies.

After all, the mainstream of the current pharmaceutical market is the prevalence of BD transactions. Everyone is part of each other, and the emphasis is on sharing risks and making money together.

Besides, the cooperation proposed by Qingshan Pharmaceutical this time is not to buy out the patent, and it will not even conflict with the "BI-toxin filtering catalyst" currently developed by the company...

Unexpectedly, under such circumstances, President Dusman refused without even asking the price.

"Mr. President, they offered a price of 5000 million US dollars..."

"If you think it's too low, we can talk to them again and even add a clause for proportional profit sharing for some new drugs!"

"After all, cooperating with them will not affect the normal research and development of our 'BI-Toxin Filter Catalyst', and we can also obtain a good amount of funds."

"No, it's not necessary."

Dusman shook his head again and refused decisively.

For him, he doesn't really like this kind of business cooperation. Instead, he prefers to devote all his energy to drug research and development and make money through drugs.

After saying this, he did not forget to remind:
"Hans, you should pay more attention to the progress of the R&D team and find out as soon as possible why the new drug has only a 2-3% effective clearance rate."

Hans pouted helplessly:
"Okay, Mr. President, I will reply to Qingshan Pharmaceutical truthfully."

……

"Zhang, I reported it to the president for you, but he refused."

"Oh, do you think the price is too low?"

"No, Mr. President has no interest in cooperation at all. We prefer to focus more on drug research and development rather than commercial cooperation."

Zhang Yang soon received a reply from Hans. He was somewhat surprised but also found the reason reasonable.

Among developed countries in the world, German pharmaceutical companies conduct the fewest BD transactions each year, with the number of transactions being only one-tenth of that in the United States.

You can say they are conservative or old-fashioned, but this seems to be a preference engraved in their genes.

However, this result made Zhang Yang feel a little desperate. BI Company had no intention of cooperating, which meant that he could not obtain the patent for the "toxin filtering catalyst", and there was no way to develop a catalyst that worked on the human body based on this.

"What should I do?"

Zhang Yang's mind was working rapidly. The current situation had become clearer and he could no longer wait for BI Company to change its mind.

The only way...

Put pressure on the Germans.

Zhang Yang's eyes lit up. After all, BI Company developed the "BI-Toxin Filter Catalyst" to make money, not for love. They really wanted to put it on the market for sale.

If a competing product similar to "BI-Toxin Filter Catalyst" appears at this time, it will inevitably put BI company under tremendous pressure.

No matter how stubborn the Germans are, under pressure they will begin to seriously weigh the market price, weigh the market prospects if they are slow to develop, and really consider whether to engage in business cooperation to reduce risks!
"This competitor can be Qingshan Pharmaceutical. With its current international reputation, Qingshan Pharmaceutical can definitely put pressure on the Germans."

"Besides, whether it's true or not, this plan is not just to put pressure on the Germans. On the other hand, we really need to start drug research and development in the field of 'macromolecule toxin catalysts'!"

As Zhang Yang thought about it, his thoughts became clearer.

"Beyond this, we must also start further research on the 'BI-toxin filtering catalyst'."

"We don't know the details of BI-Toxin Filtration Catalyst yet, and we are still unsure whether it will be effective when used with Kidney Toxin Clearing Dialysis Needle. These will affect our subsequent price assessment of the drug patent."

"Only after doing enough research now and truly understanding the effects of 'BI-Toxin Filter Catalyst', can we know whether it is worth pursuing it and how much it is worth to buy it out, so that we can have a clear idea."

Thirty minutes later, a blank page of the notebook was filled with Zhang Yang's plan. After careful consideration again, he called Fang Hanliang.

Fang Hanliang has not been in a hurry to set up a project these days. He has been checking the information of the team members of the R&D center and forming his own R&D team.

That's just right.

"Fang Bo, to make a long story short, you know that I am very interested in BI's 'Toxin Filtration Catalyst'."

"Today I contacted their vice president Hans and proposed cooperation, but they directly rejected it."

"I have a task for you now. I want to make a copy of 'BI-Toxin Filtering Catalyst' as soon as possible. I want to know whether 'Toxin Filtering Catalyst' is effective when combined with 'Kidney Toxin Clearing'! If so, what effect can it achieve!"

"In addition, we can't put all our hopes on BI. We need to develop a similar catalyst that can decompose large molecular toxins."

Fang Hanliang understood immediately and his face turned bitter:

"Mr. Zhang, this is not one task, this is two tasks."

　There are 500 monthly tickets for National Day, 5 more chapters, -1 chapter owed, 5 more chapters owed

　　
　
(End of this chapter)